[How do aspirin and company work? Cyclooxygenases--point of attack of nonsteroidal antirheumatics].
作者信息
Steinhilber Dieter
机构信息
Institut für Pharmazeutische Chemie Johann Wolfgang Goethe-Universität Frankfurt Marie-Curie-Str. 9 60439 Frankfurt.
出版信息
Pharm Unserer Zeit. 2002;31(2):140-4. doi: 10.1002/1615-1003(200203)31:2<140::AID-PAUZ140>3.0.CO;2-B.
Abstract
摘要
相似文献
1
[How do aspirin and company work? Cyclooxygenases--point of attack of nonsteroidal antirheumatics].
Pharm Unserer Zeit. 2002;31(2):140-4. doi: 10.1002/1615-1003(200203)31:2<140::AID-PAUZ140>3.0.CO;2-B.
2
Cox-2-selective inhibitors: the new super aspirins.
Mol Pharmacol. 1999 Apr;55(4):625-31.
3
The development of COX2 inhibitors.
Nat Rev Drug Discov. 2003 Mar;2(3):179-91. doi: 10.1038/nrd1034.
4
[COX-1 and COX-2: functions and pharmacological effects].
Pharm Unserer Zeit. 1999 Jan;28(1):21-9.
5
[Cyclooxygenases in the spinal cord and the relationship with pain].
Sheng Li Ke Xue Jin Zhan. 2003 Oct;34(4):359-60.
6
The future of NSAID therapy: selective COX-2 inhibitors.
Int J Clin Pract. 2000 Jan-Feb;54(1):7-9.
7
COX-2 inhibitors--is there cause for concern?
Nat Med. 1999 Jun;5(6):621-2. doi: 10.1038/9465.
8
[A heterogenous drug class. NSAID: classification and spectrum of action].
Pharm Unserer Zeit. 2002;31(2):146-54. doi: 10.1002/1615-1003(200203)31:2<146::AID-PAUZ146>3.0.CO;2-O.
9
The discovery and function of COX-2.
J Rheumatol Suppl. 1997 Jul;49:6-8.
10
New perspectives for nonsteroidal antiinflammatory therapy.
J Rheumatol. 1997 Feb;24(2):246-8.
Zotero 插件